121 related articles for article (PubMed ID: 23467929)
21. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
Balasenthil S; Barnes CJ; Rayala SK; Kumar R
FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
[TBL] [Abstract][Full Text] [Related]
23. miR-888 in MCF-7 side population sphere cells directly targets E-cadherin.
Huang S; Cai M; Zheng Y; Zhou L; Wang Q; Chen L
J Genet Genomics; 2014 Jan; 41(1):35-42. PubMed ID: 24480745
[TBL] [Abstract][Full Text] [Related]
24. Nuclear Localization Signal-Enhanced Polyurethane-Short Branch Polyethylenimine-Mediated Delivery of Let-7a Inhibited Cancer Stem-Like Properties by Targeting the 3'-UTR of HMGA2 in Anaplastic Astrocytoma.
Yang MY; Chen MT; Huang PI; Wang CY; Chang YC; Yang YP; Lo WL; Sung WH; Liao YW; Lee YY; Chang YL; Tseng LM; Chen YW; Ma HI
Cell Transplant; 2015; 24(8):1431-50. PubMed ID: 24898358
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer.
Lyu S; Yu Q; Ying G; Wang S; Wang Y; Zhang J; Niu Y
Int J Oncol; 2014 Jan; 44(1):229-37. PubMed ID: 24172884
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome.
Wang G; Gormley M; Qiao J; Zhao Q; Wang M; Di Sante G; Deng S; Dong L; Pestell T; Ju X; Casimiro MC; Addya S; Ertel A; Tozeren A; Li Q; Yu Z; Pestell RG
Theranostics; 2018; 8(8):2251-2263. PubMed ID: 29721077
[No Abstract] [Full Text] [Related]
27. let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.
Zhao Y; Deng C; Lu W; Xiao J; Ma D; Guo M; Recker RR; Gatalica Z; Wang Z; Xiao GG
Mol Med; 2011; 17(11-12):1233-41. PubMed ID: 21826373
[TBL] [Abstract][Full Text] [Related]
28. Let-7a regulates mammosphere formation capacity through Ras/NF-κB and Ras/MAPK/ERK pathway in breast cancer stem cells.
Xu C; Sun X; Qin S; Wang H; Zheng Z; Xu S; Luo G; Liu P; Liu J; Du N; Zhang Y; Liu D; Ren H
Cell Cycle; 2015; 14(11):1686-97. PubMed ID: 25955298
[TBL] [Abstract][Full Text] [Related]
29. Let‑7 miRNAs sensitize breast cancer stem cells to radiation‑induced repression through inhibition of the cyclin D1/Akt1/Wnt1 signaling pathway.
Sun H; Ding C; Zhang H; Gao J
Mol Med Rep; 2016 Oct; 14(4):3285-92. PubMed ID: 27574028
[TBL] [Abstract][Full Text] [Related]
30. Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1.
Liu K; Zhang C; Li T; Ding Y; Tu T; Zhou F; Qi W; Chen H; Sun X
Int J Oncol; 2015; 46(6):2526-34. PubMed ID: 25846193
[TBL] [Abstract][Full Text] [Related]
31. The effect of hesperetin on estrogen receptor gene expression and its relationship with the downstream pathways of estrogen receptor alpha.
Bideh M; Safari S; Khedri A; Zangooei M
Mol Biol Rep; 2023 Sep; 50(9):7225-7236. PubMed ID: 37418087
[TBL] [Abstract][Full Text] [Related]
32. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.
Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E
Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981
[TBL] [Abstract][Full Text] [Related]
33. LIN28: a regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer.
Sakurai M; Miki Y; Masuda M; Hata S; Shibahara Y; Hirakawa H; Suzuki T; Sasano H
J Steroid Biochem Mol Biol; 2012 Sep; 131(3-5):101-6. PubMed ID: 22081076
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2.
Zhang Y; Eades G; Yao Y; Li Q; Zhou Q
J Biol Chem; 2012 Nov; 287(49):41514-22. PubMed ID: 23060440
[TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor α-coupled Bmi1 regulation pathway in breast cancer and its clinical implications.
Wang H; Liu H; Li X; Zhao J; Zhang H; Mao J; Zou Y; Zhang H; Zhang S; Hou W; Hou L; McNutt MA; Zhang B
BMC Cancer; 2014 Feb; 14():122. PubMed ID: 24559156
[TBL] [Abstract][Full Text] [Related]
36. Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway.
Wang L; Wang YX; Zhang DZ; Fang XJ; Sun PS; Xue HC
Biomed Pharmacother; 2016 Mar; 78():301-307. PubMed ID: 26898455
[TBL] [Abstract][Full Text] [Related]
37. Targeting cancer stem cells in breast cancer: potential anticancer properties of 6-shogaol and pterostilbene.
Wu CH; Hong BH; Ho CT; Yen GC
J Agric Food Chem; 2015 Mar; 63(9):2432-41. PubMed ID: 25686711
[TBL] [Abstract][Full Text] [Related]
38. Do Different Stemness Markers Identify Different Pools of Cancer Stem Cells in Malignancies: A Study on ER+ and ER-Breast Cancer Cell Lines.
Chopra S; Goel S; Thakur B; Bhatia A
Pathol Oncol Res; 2020 Jan; 26(1):371-378. PubMed ID: 30361903
[TBL] [Abstract][Full Text] [Related]
39. Examining estrogen regulation of cancer stem cells through multicolor lineage tracing.
Zhang Y; Eades G; Zhou Q
Methods Mol Biol; 2014; 1204():35-44. PubMed ID: 25182759
[TBL] [Abstract][Full Text] [Related]
40. p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA.
Xu LZ; Li SS; Zhou W; Kang ZJ; Zhang QX; Kamran M; Xu J; Liang DP; Wang CL; Hou ZJ; Wan XB; Wang HJ; Lam EW; Zhao ZW; Liu Q
Oncogene; 2017 Jan; 36(3):304-317. PubMed ID: 27345399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
